Resignations at Canada's drug pricing panel raise independence questions.
作者信息
Vogel Lauren
机构信息
CMAJ.
出版信息
CMAJ. 2023 Mar 14;195(10):E378-E379. doi: 10.1503/cmaj.1096044.
Abstract
摘要
相似文献
1
Resignations at Canada's drug pricing panel raise independence questions.加拿大药品定价委员会的人员辞职引发了对其独立性的质疑。
CMAJ. 2023 Mar 14;195(10):E378-E379. doi: 10.1503/cmaj.1096044.
2
Fair pricing of "old" orphan drugs: considerations for Canada's orphan drug policy.“老”孤儿药的合理定价：对加拿大孤儿药政策的考量
CMAJ. 2015 Apr 7;187(6):422-425. doi: 10.1503/cmaj.140308. Epub 2015 Feb 23.
3
Canada's high drug prices under review.加拿大高昂的药品价格正在接受审查。
CMAJ. 2016 Sep 20;188(13):E306. doi: 10.1503/cmaj.109-5311. Epub 2016 Aug 22.
4
Canada's New Generic Pricing Policy: A Reasoned Approach to a Challenging Problem.加拿大新的仿制药定价政策：应对棘手问题的合理方法。
Healthc Policy. 2015 Aug;11(1):10-4.
5
Canada's Amendment to Patented Drug Price Regulation: A Prescription for Global Drug Cost Control?加拿大对专利药品价格监管的修订：全球药品成本控制的良方？
JAMA. 2019 Apr 23;321(16):1565-1566. doi: 10.1001/jama.2019.2280.
6
7
Carbon pricing: a win-win environmental and public health policy.碳定价：双赢的环境和公共卫生政策。
Can J Public Health. 2018 Dec;109(5-6):779-781. doi: 10.17269/s41997-018-0099-5. Epub 2018 Jun 28.
8
Canada's promise to reform drug prices left in doubt as regulator is hit by wave of resignations.随着监管机构遭遇一波辞职潮，加拿大改革药品价格的承诺存疑。
BMJ. 2023 Mar 3;380:524. doi: 10.1136/bmj.p524.
9
MPs call for removal of Health Canada's breast-implant panel members.议员呼吁罢免加拿大卫生部乳房植入物专家小组的成员。
CMAJ. 2005 Nov 8;173(10):1144. doi: 10.1503/cmaj.051329.
10
Generic drugs in Canada: an examination of tiered pricing.加拿大的仿制药：分层定价研究。
CMAJ. 2015 Oct 6;187(14):1033-1034. doi: 10.1503/cmaj.150395. Epub 2015 Jul 13.
引用本文的文献
1
[Not Available].[无可用内容]
CMAJ. 2024 Oct 6;196(33):E1157-E1159. doi: 10.1503/cmaj.240935-f.
2
does not prescribe universal, public pharmacare.未规定普遍的公共药物治疗。
CMAJ. 2024 Aug 11;196(27):E942-E943. doi: 10.1503/cmaj.240935.
Zotero 插件